
Charles River Laboratories International CRL
€ 168.45
2.4%
Quartalsbericht 2025-Q3
hinzugefügt 05.11.2025
Charles River Laboratories International Betriebsaufwand 2011-2025 | CRL
Betriebsaufwand Jährlich Charles River Laboratories International
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 607 M | 509 M | 413 M | 409 M | 325 M | 298 M | 249 M | 231 M | 220 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 607 M | 220 M | 362 M |
Betriebsaufwand anderer Aktien in der Diagnostik & Forschung
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
58 M | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
778 M | - | -17.87 % | $ 25.9 M | ||
|
Brainsway Ltd.
BWAY
|
29.2 M | $ 17.27 | 1.8 % | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
726 M | $ 15.82 | 0.44 % | $ 170 M | ||
|
Accelerate Diagnostics
AXDX
|
77.2 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
21.6 M | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
41.3 M | $ 1.55 | -4.63 % | $ 1.97 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
59.4 M | - | - | $ 562 M | ||
|
DarioHealth Corp.
DRIO
|
62.2 M | $ 12.14 | 2.1 % | $ 344 M | ||
|
DexCom
DXCM
|
1.69 B | $ 65.83 | -1.69 % | $ 25.4 B | ||
|
Castle Biosciences
CSTL
|
59.5 M | $ 39.06 | 1.11 % | $ 1.08 B | ||
|
Chembio Diagnostics
CEMI
|
28.5 M | - | 0.22 % | $ 16.8 M | ||
|
Exact Sciences Corporation
EXAS
|
2.98 B | $ 101.64 | 0.14 % | $ 18.8 B | ||
|
Danaher Corporation
DHR
|
6.71 B | $ 227.72 | 0.54 % | $ 166 B | ||
|
Fulgent Genetics
FLGT
|
181 M | $ 27.0 | -0.52 % | $ 816 M | ||
|
Global Cord Blood Corporation
CO
|
451 M | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
134 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
5.91 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
983 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
104 M | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
585 M | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
484 M | $ 19.98 | -2.82 % | $ 1.07 B | ||
|
Celcuity
CELC
|
113 M | $ 101.67 | -3.4 % | $ 4.01 B | ||
|
Enzo Biochem
ENZ
|
47.4 M | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
9.98 M | $ 3.3 | -7.82 % | $ 105 K | ||
|
Co-Diagnostics
CODX
|
45.3 M | $ 0.29 | -14.47 % | $ 8.51 M | ||
|
IQVIA Holdings
IQV
|
2.94 B | $ 222.75 | 0.24 % | $ 40.4 B | ||
|
Guardant Health
GH
|
226 M | $ 103.7 | 1.6 % | $ 12.7 B | ||
|
Aspira Women's Health
AWH
|
37.1 M | - | -6.19 % | $ 10.5 M | ||
|
Heska Corporation
HSKA
|
131 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
24.1 M | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
3.69 B | $ 134.4 | -0.35 % | $ 21.4 B | ||
|
Quotient Limited
QTNT
|
106 M | - | -11.32 % | $ 1.1 M | ||
|
Mettler-Toledo International
MTD
|
1.01 B | $ 1 410.02 | 1.15 % | $ 29.9 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.46 B | $ 183.96 | 0.79 % | $ 20.4 B | ||
|
NeoGenomics
NEO
|
382 M | $ 12.03 | 1.48 % | $ 1.52 B | ||
|
Neogen Corporation
NEOG
|
1.48 B | $ 6.85 | -0.22 % | $ 1.49 B | ||
|
Biodesix
BDSX
|
106 M | $ 7.63 | -2.8 % | $ 989 M | ||
|
Myriad Genetics
MYGN
|
709 M | $ 7.04 | -2.36 % | $ 638 M | ||
|
Laboratory Corporation of America Holdings
LH
|
1.87 B | $ 262.89 | -0.48 % | $ 22.1 B | ||
|
ICON Public Limited Company
ICLR
|
408 M | $ 184.38 | -1.18 % | $ 15.2 B | ||
|
IDEXX Laboratories
IDXX
|
1.25 B | $ 698.77 | -0.77 % | $ 57.6 B | ||
|
Lantheus Holdings
LNTH
|
123 M | $ 66.4 | -0.33 % | $ 4.59 B | ||
|
Agilent Technologies
A
|
1.99 B | $ 140.3 | 0.46 % | $ 42.7 B | ||
|
Biomerica
BMRA
|
5.64 M | $ 2.48 | -2.65 % | $ 5.7 M | ||
|
Bioventus
BVS
|
217 M | $ 7.49 | -0.86 % | $ 469 M | ||
|
Check-Cap Ltd.
CHEK
|
14.1 M | - | - | $ 9.42 M | ||
|
Pacific Biosciences of California
PACB
|
387 M | $ 2.13 | 0.24 % | $ 540 M | ||
|
Motus GI Holdings
MOTS
|
18.6 M | - | -34.28 % | $ 263 K |